Trade Summary

1 week ago, Lee Kevin, serving as CHIEF EXECUTIVE OFFICER at BICYCLE THERAPEUTICS PLC (BCYC), sold 7,642 shares at $4.28 per share, for a total transaction value of $32,700.82. Following this transaction, Lee Kevin now holds 603,671 shares of BCYC.

This sale represents a 1.25% decrease in Lee Kevin's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, July 2, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 5:00 PM ET, 5 days after the trade was made.

BICYCLE THERAPEUTICS PLC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.